Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Taiwanese (TAIEX) Healthcare Sector Analysis

UpdatedJul 02, 2026
DataAggregated Company Financials
Companies230
  • 7D3.9%
  • 3M17.6%
  • 1Y8.2%
  • YTD9.3%

The Healthcare industry is up 3.9% in the last week, with PharmaEssentia up 17%. Meanwhile, Caliway Biopharmaceuticals actually underperformed within the industry, shrinking 5.1% in the last week. This means that the industry has gained 8.2% over the past year. As for the next few years, earnings are expected to grow by 59% per annum.

Sector Valuation and Performance

Has the Taiwanese Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 02 Jul 2026NT$1.9tNT$277.3bNT$17.7b19x107.6x6.9x
Sat, 30 May 2026NT$1.6tNT$277.3bNT$17.8b18.5x92.5x5.9x
Mon, 27 Apr 2026NT$1.6tNT$270.3bNT$18.0b19x88.9x5.9x
Wed, 25 Mar 2026NT$1.6tNT$270.3bNT$17.7b18.6x89.2x5.8x
Fri, 20 Feb 2026NT$1.8tNT$269.0bNT$11.5b19x157.3x6.7x
Sun, 18 Jan 2026NT$1.8tNT$268.8bNT$13.4b19.2x134.2x6.7x
Tue, 16 Dec 2025NT$1.7tNT$267.4bNT$13.6b19.1x126.8x6.5x
Thu, 13 Nov 2025NT$1.6tNT$268.4bNT$12.5b21.5x132.1x6.1x
Sat, 11 Oct 2025NT$1.8tNT$266.8bNT$8.4b21.9x208.8x6.6x
Mon, 08 Sep 2025NT$1.9tNT$266.1bNT$8.7b22.8x218x7.1x
Wed, 06 Aug 2025NT$1.6tNT$261.6bNT$15.0b21.2x110.3x6.3x
Fri, 04 Jul 2025NT$1.6tNT$261.0bNT$16.4b19.7x100.5x6.3x
Sun, 01 Jun 2025NT$1.5tNT$260.7bNT$16.3b19.5x92.5x5.8x
Tue, 29 Apr 2025NT$1.4tNT$254.7bNT$12.0b19.5x116.3x5.5x
Thu, 27 Mar 2025NT$1.6tNT$254.1bNT$11.7b21.7x138.2x6.3x
Sat, 22 Feb 2025NT$1.7tNT$246.5bNT$8.4b24.1x197x6.7x
Mon, 20 Jan 2025NT$1.5tNT$246.2bNT$8.7b21.9x174x6.2x
Wed, 18 Dec 2024NT$1.4tNT$220.5bNT$7.3b21.9x196.4x6.5x
Fri, 15 Nov 2024NT$1.5tNT$238.4bNT$7.4b23.4x202.8x6.3x
Sun, 13 Oct 2024NT$1.5tNT$236.4bNT$6.8b24.5x225.5x6.4x
Tue, 10 Sep 2024NT$1.6tNT$236.4bNT$6.8b25.4x232.9x6.7x
Thu, 08 Aug 2024NT$1.5tNT$229.3bNT$3.6b27.2x427x6.7x
Sat, 06 Jul 2024NT$1.7tNT$228.8bNT$3.6b30x465x7.3x
Mon, 03 Jun 2024NT$1.5tNT$228.6bNT$3.9b26x382x6.5x
Wed, 01 May 2024NT$1.4tNT$228.8bNT$4.3b25.5x340.3x6.3x
Fri, 29 Mar 2024NT$1.5tNT$228.9bNT$7.2b25.7x201.1x6.4x
Sun, 25 Feb 2024NT$1.5tNT$225.8bNT$6.5b25.3x225x6.4x
Tue, 23 Jan 2024NT$1.4tNT$225.0bNT$5.9b24.7x235x6.2x
Thu, 21 Dec 2023NT$1.4tNT$224.7bNT$5.9b25.1x240.1x6.3x
Sat, 18 Nov 2023NT$1.4tNT$224.1bNT$6.4b25.1x216.1x6.2x
Mon, 16 Oct 2023NT$1.3tNT$225.3bNT$8.3b24.9x162.9x6x
Wed, 13 Sep 2023NT$1.4tNT$225.2bNT$8.4b25.2x162.9x6.1x
Fri, 11 Aug 2023NT$1.4tNT$225.9bNT$10.9b25.2x128x6.2x
Sun, 09 Jul 2023NT$1.4tNT$226.5bNT$11.5b25.6x124.3x6.3x
Price to Earnings Ratio

124.3x


Total Market Cap: NT$1.4tTotal Earnings: NT$11.5bTotal Revenue: NT$226.5bTotal Market Cap vs Earnings and Revenue0%0%0%
Taiwanese Healthcare Sector Price to Earnings3Y Average 188.6x202420252026
Current Industry PE
  • Investors are pessimistic on the Taiwanese Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 108x which is lower than its 3-year average PE of 189x.
  • The industry is trading close to its 3-year average PS ratio of 6.3x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have grown 15% per year over the last three years.
  • Revenues for these companies have grown 7.0% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Taiwanese Healthcare sector?

TW Market1.73%
Healthcare3.95%
Biotech10.11%
Healthcare Services-0.25%
Medical Equipment-0.64%
Pharma-1.67%
Healthtech-1.77%
Life Sciences-3.10%
Industry PE
  • Investors are most optimistic about the Healthtech industry which is trading above its 3-year average PE ratio of 64.8x.
    • It looks like they are confident that earnings will grow faster in the future than they have historically.
Forecasted Growth
  • Analysts are most optimistic on the Pharma industry, expecting annual earnings growth of 86% over the next 5 years.
  • This is better than its past earnings decline of 5.0% per year.
  • In contrast, the Medical Equipment industry is expected to see its earnings grow by 25% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
6446 PharmaEssentiaNT$1.40k16.7%
+NT$74.3b		178.9%PE87.4x
6586 CHO PharmaNT$135.008.4%
+NT$2.2b		235.0%PS20189.7x
6617 Gongwin Biopharm HoldingsNT$84.2025.7%
+NT$2.1b		-5.0%PS266.6x
6696 Lin BioScienceNT$418.005.7%
+NT$1.9b		199.6%PB3.2x
6491 PegavisionNT$347.006.8%
+NT$1.7b		13.4%PE16.5x

Latest News

7902
NT$38.65
Uwell Biopharma
7D
20.8%
1Y
n/a
6446
NT$1,395.00
PharmaEssentia
7D
16.7%
1Y
178.9%
6986
NT$47.10
HeXun Biosciences
7D
-13.6%
1Y
-36.6%
6472
NT$432.00
Bora Pharmaceuticals
7D
3.0%
1Y
-35.5%
Narrative Update • Jun 25

6472: Higher Future P/E Assumptions Will Support Long Term Earnings Power

The analyst price target for Bora Pharmaceuticals has changed slightly from NT$698.22 to NT$700.86. Analysts attribute this revision to updated assumptions for revenue growth, profit margins and future P/E, which are viewed as key drivers of the new valuation.
6569
NT$104.50
Onyx Healthcare
7D
-6.7%
1Y
-9.1%
6919
NT$96.60
Caliway Biopharmaceuticals
7D
-2.7%
1Y
-27.4%
7827
NT$162.00
HanchorBio
7D
-4.1%
1Y
141.1%
6467
NT$109.50
Taho Pharmaceuticals
7D
-10.6%
1Y
115.1%
6617
NT$84.20
Gongwin Biopharm Holdings
7D
25.7%
1Y
-5.0%
4743
NT$52.10
Oneness Biotech
7D
3.8%
1Y
-18.3%
6535
NT$98.10
Lumosa Therapeutics
7D
-1.7%
1Y
-31.6%
6491
NT$347.00
Pegavision
7D
6.8%
1Y
13.4%
6586
NT$135.00
CHO Pharma
7D
8.4%
1Y
235.0%
6634
NT$69.20
Sinew Pharma
7D
-12.3%
1Y
37.6%
6891
NT$45.85
Locus Cell
7D
-7.7%
1Y
113.3%
6696
NT$418.00
Lin BioScience
7D
5.7%
1Y
199.6%